Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®
dc.contributor.author | Bousquet, J | |
dc.contributor.author | Sousa-Pinto, B | |
dc.contributor.author | Anto, JM | |
dc.contributor.author | Bedbrook, A | |
dc.contributor.author | Czarlewski, W | |
dc.contributor.author | Ansotegui, IJ | |
dc.contributor.author | Bergmann, KC | |
dc.contributor.author | Braido, F | |
dc.contributor.author | Brussino, L | |
dc.contributor.author | Cecchi, L | |
dc.contributor.author | Loureiro, CC | |
dc.contributor.author | Cruz, AA | |
dc.contributor.author | Devillier, P | |
dc.contributor.author | Fiocchi, A | |
dc.contributor.author | Gemicioglu, B | |
dc.contributor.author | Haahtela, T | |
dc.contributor.author | Ivancevich, JC | |
dc.contributor.author | Klimek, L | |
dc.contributor.author | Kulus, M | |
dc.contributor.author | Kuna, P | |
dc.contributor.author | Kupczyk, M | |
dc.contributor.author | Kvedariene, V | |
dc.contributor.author | Larenas-Linnemann, DE | |
dc.contributor.author | Louis, G | |
dc.contributor.author | Louis, R | |
dc.contributor.author | Makris, M | |
dc.contributor.author | Morais-Almeida, M | |
dc.contributor.author | Niedoszytko, M | |
dc.contributor.author | Ohta, K | |
dc.contributor.author | Ollert, M | |
dc.contributor.author | Papadopoulos, N | |
dc.contributor.author | Patella, V | |
dc.contributor.author | Pétré, B | |
dc.contributor.author | Pfaar, O | |
dc.contributor.author | Puggioni, F | |
dc.contributor.author | Quirce, S | |
dc.contributor.author | Regateiro, FS | |
dc.contributor.author | Roche, N | |
dc.contributor.author | Rouadi, PW | |
dc.contributor.author | Samolinski, B | |
dc.contributor.author | Sastre, J | |
dc.contributor.author | Schleich, F | |
dc.contributor.author | Scichilone, N | |
dc.contributor.author | Taborda-Barata, L | |
dc.contributor.author | Toppila-Salmi, S | |
dc.contributor.author | Valiulis, A | |
dc.contributor.author | Koyuncu, IV | |
dc.contributor.author | Ventura, MT | |
dc.contributor.author | Yorgancioglu, A | |
dc.contributor.author | Fonseca, JA | |
dc.contributor.author | Zuberbier, T | |
dc.date.accessioned | 2025-04-10T10:38:01Z | |
dc.date.available | 2025-04-10T10:38:01Z | |
dc.description.abstract | Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air (R) (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air (R) in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness. | |
dc.identifier.e-issn | 2045-7022 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14701/43292 | |
dc.language.iso | English | |
dc.title | Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air® | |
dc.type | Article |